GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | 8/21/2026 6:29:20 AM | View | Proxy | SEC | Y 2025 | ||||||
| Theravance Biopharma, Inc. (TBPH) | 8/11/2026 8:10:41 AM | Small | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $20,731,000 -20.9% | Assets $469,770,000 | EPS -$0.11 | |
| Theravance Biopharma, Inc. (TBPH) | 8/10/2026 8:35:46 AM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $20,731,000 -20.9% | Assets $469,770,000 | EPS -$0.11 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 5/7/2026 9:14:45 AM | Small | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $17,699,000 +15.0% | Assets $472,313,000 | EPS -$0.10 | |
| Theravance Biopharma, Inc. (TBPH) | 5/7/2026 8:37:51 AM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $17,699,000 +15.0% | Assets $472,313,000 | EPS -$0.10 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 4/28/2026 6:16:58 PM | View | Proxy | SEC | Y 2025 | ||||||
| Theravance Biopharma, Inc. (TBPH) | 3/23/2026 8:55:55 AM | Small | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $107,464,000 +66.9% | Assets $485,570,000 | EPS $2.06 | |
| Theravance Biopharma, Inc. (TBPH) | 3/19/2026 8:38:57 AM | View | Financials | Earnings | SEC | Y 2025 | Rev $45,891,000 +144.7% | Assets $485,570,000 | EPS $1.15 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 11/12/2025 4:22:45 PM | Small | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $19,990,000 +18.5% | Assets $415,460,000 | EPS $0.07 | |
| Theravance Biopharma, Inc. (TBPH) | 11/10/2025 4:13:36 PM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $19,990,000 +18.5% | Assets $415,460,000 | EPS $0.07 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 8/13/2025 5:25:33 PM | Small | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $26,195,000 +83.7% | Assets $426,035,000 | EPS $1.08 | |
| Theravance Biopharma, Inc. (TBPH) | 8/12/2025 4:15:35 PM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $26,195,000 +83.7% | Assets $426,035,000 | EPS $1.08 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 5/12/2025 4:34:17 PM | Small | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $15,388,000 +6.1% | Assets $343,582,000 | EPS -$0.27 | |
| Theravance Biopharma, Inc. (TBPH) | 5/8/2025 4:34:01 PM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $15,388,000 +6.1% | Assets $343,582,000 | EPS -$0.27 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 4/10/2025 5:18:25 PM | View | Proxy | SEC | Y 2024 | ||||||
| Theravance Biopharma, Inc. (TBPH) | 3/7/2025 6:25:06 AM | Small | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $64,381,000 +12.1% | Assets $354,161,000 | EPS -$1.15 | |
| Theravance Biopharma, Inc. (TBPH) | 2/26/2025 4:14:43 PM | View | Financials | Earnings | SEC | Y 2024 | Rev $18,754,000 +6.8% | Assets $354,161,000 | EPS -$0.31 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 11/14/2024 6:21:22 AM | Small | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $16,868,000 +7.5% | Assets $356,105,000 | EPS -$0.26 | |
| Theravance Biopharma, Inc. (TBPH) | 11/12/2024 4:15:19 PM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $16,868,000 +7.5% | Assets $356,105,000 | EPS -$0.26 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 8/8/2024 5:08:50 PM | Small | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $14,256,000 +3.7% | Assets $362,029,000 | EPS -$0.34 | |
| Theravance Biopharma, Inc. (TBPH) | 8/5/2024 4:17:29 PM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $14,256,000 +3.7% | Assets $362,029,000 | EPS -$0.34 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 5/15/2024 6:45:36 AM | Small | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $14,503,000 +39.2% | Assets $371,307,000 | EPS -$0.24 | |
| Theravance Biopharma, Inc. (TBPH) | 5/13/2024 4:15:48 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $14,503,000 +39.2% | Assets $371,307,000 | EPS -$0.24 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 4/5/2024 4:20:57 PM | View | Proxy | SEC | Y 2023 | ||||||
| Theravance Biopharma, Inc. (TBPH) | 3/1/2024 4:47:01 PM | Small | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $57,424,000 +11.8% | Assets $381,999,000 | EPS -$1.00 | |
| Theravance Biopharma, Inc. (TBPH) | 2/26/2024 4:17:52 PM | View | Financials | Earnings | SEC | Y 2023 | Rev $17,565,000 +19.9% | Assets $381,999,000 | EPS -$0.17 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 11/9/2023 4:57:47 PM | Small | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $15,693,000 +26.0% | Assets $413,590,000 | EPS -$0.17 | |
| Theravance Biopharma, Inc. (TBPH) | 11/7/2023 4:54:18 PM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $15,693,000 +26.0% | Assets $413,590,000 | EPS -$0.17 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 8/9/2023 6:25:32 AM | Small | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $13,749,000 +24.4% | Assets $446,630,000 | EPS -$0.28 | |
| Theravance Biopharma, Inc. (TBPH) | 8/7/2023 4:15:22 PM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $13,749,000 +24.4% | Assets $446,630,000 | EPS -$0.28 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 5/18/2023 6:13:14 AM | Small | View | Financials | 10-Q/A | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $10,417,000 -21.1% | Assets $538,550,000 | EPS -$0.35 | |
| Theravance Biopharma, Inc. (TBPH) | 5/10/2023 6:33:11 AM | Small | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $10,417,000 -21.1% | Assets $538,550,000 | EPS -$0.35 | |
| Theravance Biopharma, Inc. (TBPH) | 5/8/2023 4:12:19 PM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $10,417,000 -21.1% | Assets $538,550,000 | EPS -$0.35 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 3/28/2023 4:07:48 PM | View | Proxy | SEC | Y 2022 | ||||||
| Theravance Biopharma, Inc. (TBPH) | 3/1/2023 4:56:46 PM | Small | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $51,346,000 -7.2% | Assets $607,400,000 | EPS $11.85 | |
| Theravance Biopharma, Inc. (TBPH) | 2/27/2023 5:01:32 PM | View | Financials | Earnings | SEC | Y 2022 | Rev $14,649,000 -2.0% | Assets $607,400,000 | EPS -$0.15 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 1/9/2023 6:08:06 AM | View | Financials | Earnings (Prelim) | SEC | Y 2022 | Export Earnings Model | ||||
| Theravance Biopharma, Inc. (TBPH) | 11/9/2022 9:36:20 AM | Small | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $12,451,000 -5.6% | Assets $763,496,000 | EPS $12.14 | |
| Theravance Biopharma, Inc. (TBPH) | 11/7/2022 4:17:45 PM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $12,451,000 -5.6% | Assets $763,496,000 | EPS $12.14 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 8/8/2022 5:29:44 PM | Small | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $11,050,000 -14.4% | Assets $360,761,000 | EPS -$0.11 | |
| Theravance Biopharma, Inc. (TBPH) | 8/4/2022 4:28:46 PM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $11,050,000 -14.4% | Assets $360,761,000 | EPS -$0.11 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 5/6/2022 5:17:08 PM | Small | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $13,196,000 -7.4% | Assets $355,359,000 | EPS -$0.34 | |
| Theravance Biopharma, Inc. (TBPH) | 5/5/2022 4:07:51 PM | View | Financials | Earnings | WIRE | 1Q 2022 | Rev $13,196,000 -7.4% | Assets $355,359,000 | EPS -$0.34 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 3/25/2022 6:08:01 AM | View | Proxy | SEC | Y 2021 | ||||||
| Theravance Biopharma, Inc. (TBPH) | 2/28/2022 5:53:49 PM | Small | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $55,311,000 -23.0% | Assets $374,819,000 | EPS -$2.87 | |
| Theravance Biopharma, Inc. (TBPH) | 2/23/2022 4:17:05 PM | View | Financials | Earnings | SEC | Y 2021 | Rev $14,946,000 -20.2% | Assets $374,819,000 | EPS -$0.43 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 11/8/2021 6:23:39 AM | Small | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $13,194,000 -27.7% | Assets $403,109,000 | EPS -$0.48 | |
| Theravance Biopharma, Inc. (TBPH) | 11/3/2021 4:29:58 PM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $13,194,000 -27.7% | Assets $403,109,000 | EPS -$0.48 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 8/5/2021 4:26:45 PM | Small | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $12,914,000 -14.0% | Assets $429,251,000 | EPS -$0.80 | |
| Theravance Biopharma, Inc. (TBPH) | 8/3/2021 4:10:35 PM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $12,914,000 -14.0% | Assets $429,251,000 | EPS -$0.80 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 5/6/2021 4:26:18 PM | Small | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $14,257,000 -28.2% | Assets $375,108,000 | EPS -$1.24 | |
| Theravance Biopharma, Inc. (TBPH) | 5/4/2021 4:20:00 PM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $14,257,000 -28.2% | Assets $375,108,000 | EPS -$1.24 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 3/22/2021 5:20:35 PM | View | Proxy | SEC | Y 2020 | ||||||
| Theravance Biopharma, Inc. (TBPH) | 2/26/2021 4:24:03 PM | Small | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $71,857,000 -2.1% | Assets $469,057,000 | EPS -$4.46 | |
| Theravance Biopharma, Inc. (TBPH) | 2/24/2021 4:34:29 PM | View | Financials | Earnings | WIRE | Y 2020 | Rev $18,730,000 -36.5% | Assets $469,057,000 | EPS -$0.92 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 2/23/2021 4:24:03 PM | View | Financials | Earnings | SEC | Y 2020 | Rev $18,730,000 -36.5% | Assets $469,057,000 | EPS -$0.92 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 11/9/2020 6:23:14 AM | Small | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $18,257,000 +46.9% | Assets $512,188,000 | EPS -$1.16 | |
| Theravance Biopharma, Inc. (TBPH) | 11/5/2020 4:45:25 PM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $18,257,000 +46.9% | Assets $512,188,000 | EPS -$1.16 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 8/10/2020 6:34:21 AM | Small | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $15,008,000 -42.6% | Assets $564,330,000 | EPS -$1.00 | |
| Theravance Biopharma, Inc. (TBPH) | 8/6/2020 4:47:34 PM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $15,008,000 -42.6% | Assets $564,330,000 | EPS -$1.00 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 5/8/2020 4:46:14 PM | Small | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $19,862,000 +272.1% | Assets $605,409,000 | EPS -$1.40 | |
| Theravance Biopharma, Inc. (TBPH) | 5/6/2020 4:47:04 PM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $19,862,000 +272.1% | Assets $605,409,000 | EPS -$1.40 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 3/24/2020 4:21:22 PM | View | Proxy | SEC | Y 2019 | ||||||
| Theravance Biopharma, Inc. (TBPH) | 2/27/2020 5:02:28 PM | Small | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $73,414,000 +21.6% | Assets $408,826,000 | EPS -$4.25 | |
| Theravance Biopharma, Inc. (TBPH) | 2/24/2020 4:13:48 PM | View | Financials | Earnings | SEC | Y 2019 | Rev $29,499,000 +87.4% | Assets $408,826,000 | EPS -$1.17 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 11/8/2019 6:47:02 AM | Small | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $12,427,000 -3.2% | Assets $445,337,000 | EPS -$1.05 | |
| Theravance Biopharma, Inc. (TBPH) | 11/5/2019 4:47:44 PM | View | Financials | Earnings | SEC | 3Q 2019 | Rev $12,427,000 -3.2% | Assets $445,337,000 | EPS -$1.05 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 8/5/2019 5:04:24 PM | Small | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $26,150,000 +11.4% | Assets $492,447,000 | EPS -$0.72 | |
| Theravance Biopharma, Inc. (TBPH) | 7/31/2019 7:11:46 AM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $26,150,000 +11.4% | Assets $492,447,000 | EPS -$0.72 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 5/10/2019 6:25:26 AM | Small | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $5,338,000 -35.8% | Assets $531,265,000 | EPS -$1.32 | |
| Theravance Biopharma, Inc. (TBPH) | 5/7/2019 4:55:03 PM | View | Financials | Earnings | SEC | 1Q 2019 | Rev $5,338,000 -35.8% | Assets $531,265,000 | EPS -$1.32 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 3/20/2019 5:20:12 PM | View | Proxy | SEC | Y 2018 | ||||||
| Theravance Biopharma, Inc. (TBPH) | 2/28/2019 6:28:01 PM | Small | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $60,370,000 +292.4% | Assets $560,235,000 | EPS -$3.99 | |
| Theravance Biopharma, Inc. (TBPH) | 2/26/2019 4:33:53 PM | View | Financials | Earnings | SEC | Y 2018 | Rev $15,737,000 +248.5% | Assets $560,235,000 | EPS -$0.92 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 11/8/2018 6:27:29 AM | Small | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $12,838,000 +200.3% | Assets $370,964,000 | EPS -$1.10 | |
| Theravance Biopharma, Inc. (TBPH) | 11/6/2018 4:23:16 PM | View | Financials | Earnings | SEC | 3Q 2018 | Rev $12,838,000 +200.3% | Assets $370,964,000 | EPS -$1.10 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 8/2/2018 6:24:05 AM | Small | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $23,476,000 +569.0% | Assets $421,364,000 | EPS -$0.76 | |
| Theravance Biopharma, Inc. (TBPH) | 8/1/2018 7:26:10 AM | View | Financials | Earnings | SEC | 2Q 2018 | Rev $23,476,000 +569.0% | Assets $421,364,000 | EPS -$0.76 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 5/9/2018 6:33:20 AM | Small | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $8,319,000 +169.5% | Assets $480,108,000 | EPS -$1.22 | |
| Theravance Biopharma, Inc. (TBPH) | 5/8/2018 4:23:29 PM | View | Financials | Earnings | SEC | 1Q 2018 | Rev $8,319,000 +169.5% | Assets $480,108,000 | EPS -$1.22 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 3/21/2018 4:45:47 PM | View | Proxy | SEC | Y 2017 | ||||||
| Theravance Biopharma, Inc. (TBPH) | 2/28/2018 4:56:54 PM | Small | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $15,386,000 -68.4% | Assets $441,400,000 | EPS -$5.45 | |
| Theravance Biopharma, Inc. (TBPH) | 2/27/2018 4:34:40 PM | View | Financials | Earnings | SEC | Y 2017 | Rev $4,515,000 -20.7% | Assets $441,400,000 | EPS -$1.64 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 11/8/2017 6:15:32 AM | Small | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $4,275,000 -77.6% | Assets $486,159,000 | EPS -$1.27 | |
| Theravance Biopharma, Inc. (TBPH) | 11/7/2017 4:06:02 PM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $4,275,000 -77.6% | Assets $486,159,000 | EPS -$1.27 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 8/9/2017 6:12:32 AM | Small | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $3,509,000 -35.9% | Assets $543,886,000 | EPS -$1.27 | |
| Theravance Biopharma, Inc. (TBPH) | 8/8/2017 4:27:12 PM | View | Financials | Earnings | SEC | 2Q 2017 | Rev $3,509,000 -35.9% | Assets $543,886,000 | EPS -$1.27 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 5/10/2017 6:16:51 AM | Small | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $3,087,000 -83.2% | Assets $588,039,000 | EPS -$1.27 | |
| Theravance Biopharma, Inc. (TBPH) | 5/10/2017 6:00:43 AM | View | Conf. Call | SEC | 2Q 2017 | ||||||
| Theravance Biopharma, Inc. (TBPH) | 5/9/2017 4:26:40 PM | View | Financials | Earnings | SEC | 1Q 2017 | Rev $3,087,000 -83.2% | Assets $588,039,000 | EPS -$1.27 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 4/11/2017 4:15:25 PM | View | Proxy | SEC | Y 2016 | ||||||
| Theravance Biopharma, Inc. (TBPH) | 3/1/2017 6:09:17 AM | Small | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $48,648,000 +15.5% | Assets $639,254,000 | EPS -$4.26 | |
| Theravance Biopharma, Inc. (TBPH) | 2/27/2017 4:07:37 PM | View | Financials | Earnings | SEC | Y 2016 | Rev $5,692,000 +46.2% | Assets $639,254,000 | EPS -$1.36 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 11/9/2016 5:30:00 AM | Small | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $19,075,000 +78.3% | Assets $356,289,000 | EPS -$0.73 | |
| Theravance Biopharma, Inc. (TBPH) | 11/8/2016 4:09:09 PM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $19,075,000 +78.3% | Assets $356,289,000 | EPS -$0.73 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 8/9/2016 5:30:00 AM | Small | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $5,471,000 -23.3% | Assets $374,488,000 | EPS -$1.06 | |
| Theravance Biopharma, Inc. (TBPH) | 8/8/2016 4:15:21 PM | View | Financials | Earnings | SEC | 2Q 2016 | Rev $5,471,000 -23.3% | Assets $374,488,000 | EPS -$1.06 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 5/10/2016 4:02:41 PM | Small | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $18,410,000 -9.8% | Assets $293,125,000 | EPS -$1.10 | |
| Theravance Biopharma, Inc. (TBPH) | 5/9/2016 4:16:21 PM | View | Financials | Earnings | SEC | 1Q 2016 | Rev $18,410,000 -9.8% | Assets $293,125,000 | EPS -$1.10 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 3/25/2016 4:37:35 PM | View | Proxy | SEC | Y 2015 | ||||||
| Theravance Biopharma, Inc. (TBPH) | 3/11/2016 5:10:30 PM | Small | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $42,126,000 +260.4% | Assets $300,116,000 | EPS -$5.34 | |
| Theravance Biopharma, Inc. (TBPH) | 3/9/2016 4:20:35 PM | View | Financials | Earnings | SEC | Y 2015 | Rev $3,893,000 +171.7% | Assets $300,116,000 | EPS -$1.23 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 1/11/2016 8:05:52 AM | View | Presentation | SEC | 1Q 2016 | ||||||
| Theravance Biopharma, Inc. (TBPH) | 11/12/2015 4:23:42 PM | Small | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Rev: $10,698,000 +68.8% | Assets $257,506,000 | EPS -$1.40 | |
| Theravance Biopharma, Inc. (TBPH) | 11/9/2015 4:10:14 PM | View | Financials | Earnings | SEC | 3Q 2015 | Rev $10,698,000 +68.8% | Assets $257,506,000 | EPS -$1.40 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 8/28/2015 4:39:09 PM | View | Financials | Earnings | SEC | Export Earnings Model | |||||
| Theravance Biopharma, Inc. (TBPH) | 8/13/2015 4:11:32 PM | Small | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Rev: $7,134,000 +139.9% | Assets $289,479,000 | EPS -$1.42 | |
| Theravance Biopharma, Inc. (TBPH) | 5/13/2015 5:03:31 PM | Small | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Rev: $20,401,000 +2,058.8% | Assets $324,901,000 | EPS -$1.29 | |
| Theravance Biopharma, Inc. (TBPH) | 5/7/2015 4:15:16 PM | View | Financials | Earnings | SEC | 1Q 2015 | Rev $20,401,000 +2,058.8% | Assets $324,901,000 | EPS -$1.29 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 3/17/2015 5:22:43 PM | View | Proxy | SEC | Y 2014 | ||||||
| Theravance Biopharma, Inc. (TBPH) | 3/13/2015 4:50:57 PM | Small | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Rev: $11,688,000 +5,071.7% | Assets $337,771,000 | EPS -$7.46 | |
| Theravance Biopharma, Inc. (TBPH) | 3/10/2015 4:43:20 PM | View | Financials | Earnings | SEC | Y 2014 | Rev $1,433,000 +718.9% | Assets $337,771,000 | EPS -$2.02 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 11/12/2014 4:13:31 PM | Small | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Rev: $6,336,000 +26,300.0% | Assets $381,705,000 | EPS -$1.72 | |
| Theravance Biopharma, Inc. (TBPH) | 11/6/2014 4:10:51 PM | View | Financials | Earnings | SEC | 3Q 2014 | Rev $6,336,000 +26,300.0% | Assets $381,705,000 | EPS -$1.72 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 8/14/2014 5:30:00 AM | Small | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Rev: $2,974,000 +59,380.0% | Assets $430,588,000 | EPS -$1.83 | |
| Theravance Biopharma, Inc. (TBPH) | 8/13/2014 4:15:27 PM | View | Financials | Earnings | SEC | 2Q 2014 | Rev $2,974,000 +59,380.0% | Assets $430,588,000 | EPS -$1.83 | Export Earnings Model | |
| Theravance Biopharma, Inc. (TBPH) | 6/24/2014 5:16:34 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Rev: $945,000 +4,195.5% | Assets $26,167,000 | EPS -$1.89 |